Overview

Overview

Promoted products

Pharmaceutical brands that solve unmet needs in the markets for health care providers, physicians and patients – currently 2 main franchises: rheumathoid arthritis, medical termination of pregnancy.

Methotrexate​
Mifepristone​

Methotrexate​

Non promoted products

Range of classical generics at attractive price/volume combinations spanning many TAs and technology types

Hard-to-Make generics threatened by supply shortages for payors and wholesalers

Desmopressin​
Tranezamic acid

Branded generics that fulfill government-designated public health needs such as in HIV in Russia; these products bridge transition during originator patent expiry

Antiretrovirals​
Anticancer​

Pharmaceutical Services​

Pharmaceutical development and production services with unique capabilities (e.g., polymers)

Dev‘t and mfg
capabilities​

Polymer
technology​

Drug rediscovery in new and higher value indications for institutions and consortia​

Drug repurposing​

Geographies

Commercially, Sever companies operate mainly in US and Canada, Western Europe, Russia, Japan

Manufacturing​

Sever has 4 development and manufacturing sites across the world and cover a range of technologies from oral solids to poymers

Farmaprim​
Moldova​

Izvarino and
Nanopharm​
Russia​

Malmö​
Sweden​